EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells-Reference-Cited by-同舟云学术

EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells

Published:2017-07-18 Issue:5 Volume:40 Page:483-496
ISSN:2211-3428
Container-title:Cellular Oncology
language:en
Short-container-title:Cell Oncol.

Author:

La Rocca Francesco,Airoldi Irma,Di Carlo Emma,Marotta Pina,Falco Geppino,Simeon Vittorio,Laurenzana Ilaria,Trino Stefania,De Luca Luciana,Todoerti Katia,Villani Oreste,Lackmann Martin,D’Auria Fiorella,Frassoni Francesco,Neri Antonino,Del Vecchio Luigi,Musto Pellegrino,Cilloni Daniela,Caivano Antonella^ORCID

Funder

Ministero della Salute

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine,General Medicine

Link

http://link.springer.com/article/10.1007/s13402-017-0338-4/fulltext.html

Reference51 articles.

1. A. Palumbo, K. Anderson, Multiple myeloma. N Engl J Med 364, 1046–1060 (2011)

2. A.K. Stewart, S.V. Rajkumar, M.A. Dimopoulos, T. Masszi, I. Špika, A. Oriol, R. Hájek, L. Rosiñol, D.S. Siegel, G.G. Mihaylov, V. Goranova-Marinova, P. Rajnics, A. Suvorov, R. Niesvizky, A.J. Jakubowiak, J.F. San-Miguel, H. Ludwig, M. Wang, V. Maisnar, J. Minarik, W.I. Bensinger, M.V. Mateos, D. Ben-Yehuda, V. Kukreti, N. Zojwalla, M.E. Tonda, X. Yang, B. Xing, P. Moreau, A. Palumbo, Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma. N Engl J Med 372, 142–152 (2015)

3. M.A. Dimopoulos, P.G. Richardson, P. Moreau, K.C. Anderson, Current treatment landscape for relapsed and/or refractory multiple myeloma. Nat Rev Clin Oncol 12, 42–54 (2014)